The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats
Authors
Keywords
Balkan endemic nephropathy, Aristolochic acid nephropathy, Aristolochic acid, Ochratoxin A, DNA adducts
Journal
ARCHIVES OF TOXICOLOGY
Volume 89, Issue 11, Pages 2141-2158
Publisher
Springer Nature
Online
2014-09-10
DOI
10.1007/s00204-014-1360-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats
- (2014) Marie Stiborová et al. MUTAGENESIS
- The effect of aristolochic acid I on expression of NAD(P)H:quinone oxidoreductase in mice and rats—A comparative study
- (2014) František Bárta et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy
- (2013) M. Refik Gökmen et al. ANNALS OF INTERNAL MEDICINE
- Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells — up regulation of Nrf2 expression and down regulation of NF-κB and COX-2
- (2013) Periasamy Ramyaa et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Induced Expression of Cytochrome P450 1A and NAD(P)H:Quinone Oxidoreductase Determined at mRNA, Protein, and Enzyme Activity Levels in Rats Exposed to the Carcinogenic Azo Dye 1-Phenylazo-2-naphthol (Sudan I)
- (2013) Marie Stiborová et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Drug interactions with solid tumour-targeted therapies
- (2013) Audrey Thomas-Schoemann et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Enzymes Metabolizing Aristolochic Acid and their Contribution to the Development of Aristolochic Acid Nephropathy and Urothelial Cancer
- (2013) Marie Stiborova et al. CURRENT DRUG METABOLISM
- Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy
- (2013) Heinz H. Schmeiser et al. INTERNATIONAL JOURNAL OF CANCER
- Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
- (2013) S. L. Poon et al. Science Translational Medicine
- Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing
- (2013) M. L. Hoang et al. Science Translational Medicine
- Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid
- (2013) Marie Stiborová et al. XENOBIOTICA
- Biomonitoring of Aristolactam-DNA Adducts in Human Tissues Using Ultra-Performance Liquid Chromatography/Ion-Trap Mass Spectrometry
- (2012) Byeong Hwa Yun et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania
- (2012) Heinz H. Schmeiser et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy
- (2012) Marc E. De Broe KIDNEY INTERNATIONAL
- Aristolochic acid-associated urothelial cancer in Taiwan
- (2012) C.-H. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I
- (2012) Katerina Levova et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cells
- (2012) Shaohua Zhu et al. TOXICOLOGY IN VITRO
- Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats
- (2012) Alice Zachařová et al. XENOBIOTICA
- Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat
- (2011) Rostislav Večeřa et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Structure–Activity Relationships Imply Different Mechanisms of Action for Ochratoxin A-Mediated Cytotoxicity and Genotoxicity
- (2011) Kheira Hadjeba-Medjdoub et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Aristolochic Acid I Metabolism in the Isolated Perfused Rat Kidney
- (2011) Horacio A. Priestap et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies inCyp1a1(−/−),Cyp1a2(−/−), andCyp1a1/1a2(−/−)Mice
- (2011) Volker M. Arlt et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases
- (2011) Marie Stiborová et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Kidney and liver distribution of ochratoxin A in male and female F344 rats
- (2011) Ariane Vettorazzi et al. FOOD AND CHEMICAL TOXICOLOGY
- TP53 Mutational signature for aristolochic acid: an environmental carcinogen
- (2011) Masaaki Moriya et al. INTERNATIONAL JOURNAL OF CANCER
- Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
- (2011) Bojan Jelaković et al. KIDNEY INTERNATIONAL
- Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model
- (2011) Kateřina Levová et al. TOXICOLOGICAL SCIENCES
- Bioactivation versus Detoxication of the Urothelial Carcinogen Aristolochic Acid I by Human Cytochrome P450 1A1 and 1A2
- (2011) Marie Stiborová et al. TOXICOLOGICAL SCIENCES
- Inhibition of Renal NQO1 Activity by Dicoumarol Suppresses Nitroreduction of Aristolochic Acid I and Attenuates its Nephrotoxicity
- (2011) Min Chen et al. TOXICOLOGICAL SCIENCES
- Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells
- (2011) Feng-Yih Yu et al. TOXICOLOGY IN VITRO
- Coupled Motions Direct Electrons along Human Microsomal P450 Chains
- (2011) Christopher R. Pudney et al. PLOS BIOLOGY
- NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector
- (2010) Albena T. Dinkova-Kostova et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Ochratoxin A and Aristolochic Acid Involvement in Nephropathies and Associated Urothelial Tract Tumours
- (2010) Annie Pfohl-Leszkowicz Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology
- Conformational changes of the NADPH-dependent cytochrome P450 reductase in the course of electron transfer to cytochromes P450
- (2010) Tomas Laursen et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse
- (2010) T. A. Rosenquist et al. DRUG METABOLISM AND DISPOSITION
- Presence of ochratoxin A in Tunisian blood nephropathy patients. Exposure level to OTA
- (2010) Chiraz Zaied et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice
- (2010) Volker M. Arlt et al. INTERNATIONAL JOURNAL OF CANCER
- Ochratoxin A and β2-Microglobulin in BEN Patients and Controls
- (2010) Pavlina Yordanova et al. Toxins
- Balkan Nephropathy: Evolution of Our Knowledge
- (2008) Giorgos Bamias et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Mycotoxic and Aristolochic Acid Theories of the Development of Endemic Nephropathy
- (2008) Maja Peraica et al. Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology
- Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid
- (2008) M. Stiborová et al. KIDNEY INTERNATIONAL
- Aristolochic acid nephropathy: A worldwide problem
- (2008) Frédéric D. Debelle et al. KIDNEY INTERNATIONAL
- The involvement of mycotoxins in the development of endemic nephropathy
- (2008) Maja Peraica et al. WIENER KLINISCHE WOCHENSCHRIFT
- Balkan endemic nephropathy and associated urothelial cancer
- (2008) Vladisav Stefanovic et al. Nature clinical practice. Urology
- Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy
- (2007) Marie Stiborová et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started